Structure and use of Japanese encephalitis virus envelope protein binding peptide

A technology of Japanese encephalitis virus and envelope protein, which is applied in the field of biomedicine to achieve good brain tissue targeting, important social and economic benefits, and increased uptake rate

Inactive Publication Date: 2014-08-06
INST OF RADIATION MEDICINE ACAD OF MILITARY MEDICAL SCI OF THE PLA
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, many researches on the targeted transport of drugs are to select ligands of various cell surface specific receptors as target molecules, and to specifically introduce drugs into virus-inf

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Structure and use of Japanese encephalitis virus envelope protein binding peptide
  • Structure and use of Japanese encephalitis virus envelope protein binding peptide
  • Structure and use of Japanese encephalitis virus envelope protein binding peptide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] This example mainly illustrates the screening of envelope protein-binding polypeptides.

[0040] Materials and Methods

[0041] 1. Phage Random Peptide Library Screening

[0042] Using NaHCO 3 (PH=8.6) solution Coat 100 μl of 100 μg / mL envelope protein on a 96-well ELISA plate, and place in a humid environment at 4° C. overnight. The next day, the coating solution was poured off, and 300 μL of BSA blocking solution with a concentration of 10 mg / mL was added to each well, and blocked at 37°C for 1 hour. Wash 6 times with TBST (TBS+0.5% (v / v) Tween-20). Join 1.5×10 11 pfu (in 100 μL TBST) phage (Ph.D.-12 TM Phage Display Peptide Library Kit (purchased from New England Biolabs), combined at 37°C for 1 hour, decanted the phage, and washed 10 times with TBST (TBS+0.5% (v / v) Tween-20). Use 100μl of suitable eluent (0.2M Glycine-HCl (pH2.2), 1mg / ml BSA) to elute for 7-9min at room temperature, not more than 10min, suck out the eluent into a centrifuge tube, add 15μL of ...

Embodiment 2

[0048] This example mainly illustrates the uptake of 11 binding peptides in virus-infected and uninfected cells.

[0049] Materials and Methods

[0050] 1. BHK21 cells, viruses, polypeptides JE virus is amplified by infecting BHK21 cells, then mixed, subpackaged and stored at -70°C for later use. The JE virus strain used was Jingweiyan strain. BHK21 cell culture medium is DMEM (GIBCO) medium containing 7% fetal bovine serum. A maintenance solution containing 0.7% fetal bovine serum was used for virus infection. 11 peptides were labeled with FITC during synthesis.

[0051] 2. Quantitative observation of polypeptide uptake rate in virus-infected and uninfected cells by flow cytometry BHK21 cells were cultured in DMEM medium (GIBCO) containing 7% fetal bovine serum at 37°C and 5% CO2 incubator. It was observed that the cells were in good growth state. After culturing to the logarithmic growth phase, the cells were inoculated into a 6-well cell culture plate, and 80-90% of the...

Embodiment 3

[0055] This example mainly illustrates the uptake rates of 11 binding peptides in the brains of virus-infected and uninfected mice.

[0056] Materials and Methods

[0057] Order a number of SPF three-week-old (9-11g) BALB / C female mice, weigh and group the mice in advance at the beginning of the experiment, and prepare the experimental things: each FITC-labeled polypeptide, 1mL syringe, cotton swab, electronic Name, record book. The polypeptide group was injected intraperitoneally at a dose of 20 mg / kg, and the mice in the polypeptide virus group were intraperitoneally injected with a dose of 20 mg / kg immediately after challenge. The mice were sacrificed 4 hours later, and the brain tissue was immediately taken out, fixed in 4% formaldehyde, and sent for in vivo imaging to observe the fluorescence intensity of the brain tissue.

[0058] result

[0059] In vivo imaging results showed that peptides P63, P45, P55, P36, P50, and P48 have good targeting properties in virus-infec...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to sequences and structures of a class of polypeptides specifically binding with Japanese encephalitis virus envelope protein, and an application of the polypeptides in the anti-Japanese encephalitis virus drug targeting modification technology, and belongs to the technical field of biomedicine. According to the present invention, a phage display technology is adopted to screen a random peptide library to obtain the polypeptide having the sequence of number 1-11 and specifically binding with the envelope protein, the envelope protein binding peptide screened from the phage peptide library is subjected to researches such as binding activity with Japanese encephalitis virus and brain tissue targeting property, and results show that the polypeptide P63 having good specific binding activity with Japanese encephalitis virus and Japanese encephalitis virus infection mediated brain tissue targeting property is found, and the sequence is NH2-HHWWVPSWSRWT-COOH, such that the envelope protein binding peptide and the virus-specific brain-targeting peptide P63 are expected to be used in the targeting modification technology of the anti-Japanese encephalitis virus drugs.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, relates to a drug delivery system, and more specifically relates to the sequence and structure of a polypeptide specifically bound to the envelop protein of Japanese encephalitis virus and its targeted modification in anti-Japanese encephalitis virus drugs use in technology. Background technique [0002] Japanese encephalitis virus (Japanese encephalitis virus, JEV) is one of the members of the Flavivirus genus in the family Flaviviridae. disease. Vaccination is a reliable method to control JE. Currently, there is no specific therapy for JE, but supportive therapy and symptomatic treatment. JE virus is a single-stranded positive-sense RNA virus with a total length of 11kb, which contains an open reading frame and encodes a polyprotein. In infected cells, this polyprotein is divided into at least 11 proteins. The structural proteins of the virus are coded by the first 1 / 3 of the 5' end read...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K7/08A61K47/48A61K47/42
Inventor 王升启杨静张莉丁晓然汪崇文何丽娜
Owner INST OF RADIATION MEDICINE ACAD OF MILITARY MEDICAL SCI OF THE PLA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products